Sv Life Sciences Fund Iv (gp), L.p. - Net Worth and Insider Trading
Sv Life Sciences Fund Iv (gp), L.p. Net Worth
The estimated net worth of Sv Life Sciences Fund Iv (gp), L.p. is at least $508,652 dollars as of 2024-09-20. Sv Life Sciences Fund Iv (gp), L.p. is the 10% Owner of KalVista Pharmaceuticals Inc and owns about 47,471 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $508,652. Details can be seen in Sv Life Sciences Fund Iv (gp), L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sv Life Sciences Fund Iv (gp), L.p. has not made any transactions after 2019-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sv Life Sciences Fund Iv (gp), L.p.
Sv Life Sciences Fund Iv (gp), L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sv Life Sciences Fund Iv (gp), L.p. owns 6 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Ocular Therapeutix Inc (OCUL) , and Entellus Medical Inc (ENTL) among others .
Insider Ownership Summary of Sv Life Sciences Fund Iv (gp), L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2019-04-10 | 10 percent owner |
| OCUL | Ocular Therapeutix Inc | 2014-07-24 | 10 percent owner |
| ENTL | Entellus Medical Inc | 2015-02-03 | 10 percent owner |
 | | 2013-09-24 | 10 percent owner |
| | 2013-09-03 | 10 percent owner |
| | 2010-05-03 | 10 percent owner |
Sv Life Sciences Fund Iv (gp), L.p. Latest Holdings Summary
Sv Life Sciences Fund Iv (gp), L.p. currently owns a total of 1 stock. Sv Life Sciences Fund Iv (gp), L.p. owns 47,471 shares of KalVista Pharmaceuticals Inc (KALV) as of April 10, 2019, with a value of $508,652.
Latest Holdings of Sv Life Sciences Fund Iv (gp), L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2019-04-10 | 47,471 | 10.72 | 508,652 |
Holding Weightings of Sv Life Sciences Fund Iv (gp), L.p.
Sv Life Sciences Fund Iv (gp), L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Sv Life Sciences Fund Iv (gp), L.p. has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 50,000 shares on April 10, 2019, which brought Sv Life Sciences Fund Iv (gp), L.p. around $1 Million.
Insider Trading History of Sv Life Sciences Fund Iv (gp), L.p.
- 1
Sv Life Sciences Fund Iv (gp), L.p. Trading Performance
Sv Life Sciences Fund Iv (gp), L.p. Ownership Network
Sv Life Sciences Fund Iv (gp), L.p. Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Sv Life Sciences Fund Iv (gp), L.p. is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Sv Life Sciences Fund Iv (gp), L.p. made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Sv Life Sciences Fund Iv (gp), L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Sv Life Sciences Fund Iv (gp), L.p.. You might contact Sv Life Sciences Fund Iv (gp), L.p. via mailing address: One Boston Place, 201 Washington Street, Suite 3900, Boston Ma 02108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
